Vastai Technologies has completed a $50 million Series A financing round, with 5Y Capital co-leading the investment.
Why We're Bullish on AI Drug Discovery
"Joining the Z-Generation Tide, Co-Creating New National Brands."
Leading domestic microbiome therapeutics company Unknown has recently completed a tens-of-millions-of-dollars Series B+ funding round, with continued backing from 5Y Capital.
Create Lasting, Genuine Value
Became the "first listed co-working stock."
Follow FreeS Fund's video channel for the latest observations from the world of venture capital.
Deep Digitalization Powers a "People-Centric" Supply Chain Upgrade
Low-code technology is becoming the core engine of enterprise digital transformation.
What should you do if you discover a mismatch between technology and market?
